Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREDICTRA: Adalimumab Tapering in RA Remission
NCT02198651Phase 4Completed
- Sponsor
- AbbVie Inc.
- Start
- Jan 2015
- Primary completion
- May 2018
- Modality
- Monoclonal Antibodies
- Countries
- 14
01
Overview
A Phase 4 trial of adalimumab in rheumatoid arthritis (RA), sponsored by AbbVie Inc.. Started Jan 2015; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02198651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02198651.